Status:
RECRUITING
Assess the Risk of Cerebrovascular Disease
Lead Sponsor:
Tang-Du Hospital
Conditions:
Cerebrovascular Disease
Eligibility:
All Genders
Brief Summary
Intracranial artery stenosis is an important cause of ischemic stroke, but the degree of intracranial artery stenosis is not completely matched with the symptoms of ischemic stroke. Asymptomatic carot...
Eligibility Criteria
Inclusion
- Mild stenosis group: CTA suggested carotid stenosis \< 30%;
- Moderate stenosis group: CTA suggested carotid stenosis of 30-69%;
- Severe stenosis group: CTA indicated carotid stenosis ≥70%;
Exclusion
- dementia, MMSE score \< 21;
- previous carotid stenosis related neurological symptoms or transient ischemic attack;
- other craniocerebral lesions, such as craniocerebral trauma, tumor, inflammation, and complications of great vessels (cerebral infarction or cerebral malacia);
- contraindications for MRI examination;
- recent use of psychoactive drugs or hormones.
Key Trial Info
Start Date :
October 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04443439
Start Date
October 9 2020
End Date
December 1 2026
Last Update
October 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wen Wang
Xi'an, China, 710038